Melior Announces Research Collaboration with Merck
Melior Discovery, Inc.announced that it has signed a research collaboration with Merck & Co., Inc.to evaluate the activity of select Merck neuroscience compounds utilizing elements of Melior's invivo Indication Discovery platform.
Under the terms of the agreement Merck will pay undisclosed fees for priority access to aspects of Melior's exclusively licensed platform.
Organizations
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.